BiotechTube
Home/OS Therapies/Chris Acevedo
CA

Chris Acevedo

Chief Financial Officer

OS Therapies

Therapeutic Areas

OncologyRare Diseases

OS Therapies Pipeline

DrugIndicationPhase
OST-HER2Osteosarcoma (HER2+)Phase 1

Leadership Team at OS Therapies

PR
Paul Romness
Chair, Chief Executive Officer, President
RP
Robert Petit
Chief Medical & Scientific Officer, Founding Scientist (OST-HER2)
GC
Gerald Commisiong
Chief Business Officer
JW
Jutta Wanner
Advisor, Founding Scientist (OST-tADC)
JD
Jack Doll
Chief of Staff
View full OS Therapies profile